MicrobiomE-associaTEd boosters Of immune Responses (METEOR study): experimental charac-terization and clinical exploitation.

Building a sustainable european innovation platform to enhance the repurposing of medicines for all.

Enhancing WGS and/or national infrastructures and capacities to respond to the Covid-19 pandemic in the EU

Microbiota Intervention Strategies Limiting Selection and Transmission of Antibiotic Resistance burden in the One Health domain

Preventing obesity, sarcopenia, and Sarcopenic Obesity in retirement - digital personalized interventions for healthy NUTrition and physical activity for Seniors.

Nanomedicine for glioblastoma therapy

Escherichia coli ST131: a model for high-risk transmission dynamics of antimicrobial resistance.

Malnutrition in the Elderly Knowledge Hub

The European upconversion network - from the design of photon-upconverting nanomaterials to biomedical applications (CM1403).

Cancer Nanomedicine – from the bench to the bedside (CA17140)  

Analysing the role of history, chance and selection on the evolution of plasmid-mediated antibiotic resistance (895671).

heaRt failurE paTient managEment and iNTerventIOns usiNg continuous patient monitoring outside hospitals and real world data (965343)